We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$8.8B
AUM Growth
-$819M
Cap. Flow
-$1.75B
Cap. Flow %
-19.89%
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 19.76%
3 Healthcare 14.3%
4 Real Estate 8.12%
5 Industrials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVCP
726
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$929K 0.01%
93,581
-9,368
-9% -$92.6K
HWEL
727
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$929K 0.01%
95,450
-9,555
-9% -$92.9K
OCUL icon
728
Ocular Therapeutix
OCUL
$2.02B
$926K 0.01%
223,066
-289,820
-57% -$1.46M
ACAH
729
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$919K 0.01%
93,581
-9,368
-9% -$91.9K
SPNE
730
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$915K 0.01%
161,019
+8,936
+6% +$56.8K
NCLH icon
731
PUT
Norwegian Cruise Line
NCLH
$8.84B
$904K 0.01%
69,200
BCAB icon
732
BioAtla
BCAB
$5.74M
$862K 0.01%
+2,240
New +$733K
TRGP icon
733
Targa Resources
TRGP
$55.1B
$854K 0.01%
+14,151
New +$929K
XOM icon
734
ExxonMobil
XOM
$634B
$829K 0.01%
9,500
-59,786
-86% -$5.46M
CNTB
735
Connect Biopharma Holdings
CNTB
$139M
$792K 0.01%
613,931
-37,575
-6% -$45.1K
SLN
736
Silence Therapeutics
SLN
$564M
$786K 0.01%
79,636
+50,820
+176% +$535K
NVR icon
737
NVR
NVR
$17B
$777K 0.01%
195
-302
-61% -$1.29M
SY
738
So-Young International
SY
$219M
$775K 0.01%
1,076,000
SRRK icon
739
Scholar Rock
SRRK
$6.44B
$757K 0.01%
109,250
-5,750
-5% -$47.9K
VSTM icon
740
Verastem
VSTM
$592M
$756K 0.01%
74,095
-44,820
-38% -$625K
ANNX icon
741
Annexon
ANNX
$886M
$752K 0.01%
121,757
-10,093
-8% -$54.6K
LFG
742
DELISTED
Archaea Energy Inc.
LFG
$751K 0.01%
41,719
-2,815
-6% -$49.5K
GLUE icon
743
Monte Rosa Therapeutics
GLUE
$1.34B
$748K 0.01%
91,615
-10,032
-10% -$92.1K
DAWN
744
DELISTED
Day One Biopharmaceuticals
DAWN
$741K 0.01%
+37,000
New +$787K
AMT icon
745
American Tower
AMT
$80.4B
$736K 0.01%
3,427
-88
-3% -$22.6K
FLNC icon
746
Fluence Energy
FLNC
$2.44B
$730K 0.01%
50,000
-50,000
-50% -$755K
CRC icon
747
California Resources
CRC
$4.62B
$693K 0.01%
18,026
+104
+0.6% +$4.52K
EXPE icon
748
PUT
Expedia Group
EXPE
$37.3B
$684K 0.01%
13,500
SGEN
749
DELISTED
Seagen Inc. Common Stock
SGEN
$684K 0.01%
+5,000
New +$815K
SLB icon
750
SLB Ltd
SLB
$75B
$678K 0.01%
+18,894
New +$685K

Similar funds

UBS O'Connor's Q3 2022 Portfolio in Review

As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

UBS O'Connor withdrew a net $1.75B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.

  • UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
  • UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
  • UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
  • UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
  • UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
  • UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
  • UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.